NASDAQ:TWST Twist Bioscience (TWST) Stock Price, News & Analysis $143.67 +5.57 (+4.03%) As of 12:53 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Twist Bioscience Stock (NASDAQ:TWST) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Twist Bioscience alerts:Sign Up Key Stats Today's Range$142.10▼$148.5050-Day Range$85.47▼$153.1052-Week Range$23.30▼$155.44Volume922,996 shsAverage Volume1.52 million shsMarket Capitalization$9.01 billionP/E RatioN/ADividend YieldN/APrice Target$98.45Consensus RatingModerate Buy Company Overview Twist Bioscience Corporation is a biotechnology company that develops and manufactures synthetic DNA using a proprietary silicon-based platform. The company serves researchers and organizations in biotechnology, pharmaceutical development, agriculture, industrial chemicals and academic research. Its products include synthetic genes, gene fragments, oligonucleotides and DNA libraries used in research, drug discovery, diagnostics development and other applications. Twist also provides next-generation sequencing tools and products, including target-enrichment and sample-preparation solutions, as well as synthetic biology services that support the design and testing of biological systems. Twist was founded in 2013 and is headquartered in South San Francisco, California. The company serves customers internationally through its products, services and commercial operations. Emily M. Leproust, a co-founder of Twist Bioscience, has served as the company’s chief executive officer.AI Generated. May Contain Errors. Read More Twist Bioscience Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks37th Percentile Overall ScoreTWST MarketRank™: Twist Bioscience scored higher than 37% of companies evaluated by MarketBeat, and ranked 712th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.3 / 5Analyst RatingModerate Buy Consensus RatingTwist Bioscience has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 8 buy ratings, 2 hold ratings, and 2 sell ratings.Downside RiskTwist Bioscience has a consensus price target of $98.45, representing about 31.6% downside from its current price of $143.88.Amount of Analyst CoverageTwist Bioscience has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Twist Bioscience's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Twist Bioscience are expected to grow in the coming year, from ($2.12) to ($1.56) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Twist Bioscience is -64.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Twist Bioscience is -64.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTwist Bioscience has a P/B Ratio of 18.35. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Twist Bioscience's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted19.85% of the float of Twist Bioscience has been sold short.Short Interest Ratio / Days to CoverTwist Bioscience has a short interest ratio ("days to cover") of 6.91.Change versus previous monthShort interest in Twist Bioscience has recently decreased by 14.49%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldTwist Bioscience does not currently pay a dividend.Dividend GrowthTwist Bioscience does not have a long track record of dividend growth. News and Social Media3.6 / 5News Sentiment0.76 News SentimentTwist Bioscience has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 17 news articles for Twist Bioscience this week, compared to 6 articles on an average week.Search Interest8 people have searched for TWST on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.MarketBeat Follows4 people have added Twist Bioscience to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Twist Bioscience insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $24,049,024.00 in company stock.Percentage Held by Insiders3.08% of the stock of Twist Bioscience is held by insiders.Percentage Held by InstitutionsTwist Bioscience has minimal institutional ownership at this time.Read more about Twist Bioscience's insider trading history. Receive TWST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Twist Bioscience and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TWST Stock News HeadlinesAI and Next-Gen Sequencing Strengthens Twist Bioscience Corp. (TWST)1 hour ago | insidermonkey.comTwist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery4 hours ago | markets.ft.comWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid. The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned.September 16 at 1:00 AM | Awesomely (Ad)Twist Bioscience (NASDAQ:TWST) Insider Dennis Cho Sells 412 SharesSeptember 11, 2026 | insidertrades.comBWS Financial Initiates Coverage on Twist Bioscience (NASDAQ:TWST)September 11, 2026 | americanbankingnews.comTwist Bioscience (NASDAQ:TWST) Coverage Initiated at UBS GroupSeptember 11, 2026 | americanbankingnews.comBWS Financial initiates coverage of Twist Bioscience with sell ratingSeptember 10, 2026 | msn.comTwist Bioscience (NASDAQ:TWST) CEO Emily Leproust Sells 41,570 Shares of StockAugust 28, 2026 | insidertrades.comSee More Headlines TWST Stock Analysis - Frequently Asked Questions How have TWST shares performed this year? Twist Bioscience's stock was trading at $31.72 at the beginning of the year. Since then, TWST stock has increased by 353.6% and is now trading at $143.88. How were Twist Bioscience's earnings last quarter? Twist Bioscience Corporation (NASDAQ:TWST) posted its earnings results on Monday, August, 3rd. The company reported ($0.56) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.51) by $0.05. The business's quarterly revenue was up 23.2% on a year-over-year basis. Read the conference call transcript. When did Twist Bioscience IPO? Twist Bioscience (TWST) raised $75 million in an initial public offering (IPO) on Wednesday, October 31st 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Cowen acted as the underwriters for the IPO and Allen & Company and Baird were co-managers. Who are Twist Bioscience's major shareholders? Top institutional shareholders of Twist Bioscience include BlackRock Inc. (9.30%), William Blair Investment Management LLC (3.47%), Bank of America Corp DE (1.47%) and First Light Asset Management LLC (1.16%). Insiders that own company stock include Emily M Leproust, William Banyai, Patrick John Finn, Paula Green, Adam Laponis, Dennis Cho, Robert F Werner, Melissa A Starovasnik, Robert Chess and Jan Johannessen. View institutional ownership trends. How do I buy shares of Twist Bioscience? Shares of TWST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Twist Bioscience own? Based on aggregate information from My MarketBeat watchlists, some other companies that Twist Bioscience investors own include Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), DiamondRock Hospitality (DRH), AUO (AUOTY), iShares Micro-Cap ETF (IWC) and Voyager Therapeutics (VYGR). Company Calendar Last Earnings8/03/2026Today9/16/2026Fiscal Year End9/30/2026Next Earnings (Estimated)11/13/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (8m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 TWST's financial health is in the Green zone, according to TradeSmith. TWST has been in this zone for over 8 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:TWST CIK1581280 Webwww.twistbioscience.com Phone(800) 719-0671FaxN/AEmployees979Year Founded2013Price Target and Rating Average Price Target for Twist Bioscience$98.45 High Price Target$144.00 Low Price Target$41.00 Potential Upside/Downside-31.8%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage12 Analysts Profitability EPS (Trailing Twelve Months)($2.22) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$77.67 million Net Margins-31.66% Pretax Margin-31.46% Return on Equity-28.64% Return on Assets-19.94% Debt Debt-to-Equity Ratio0.03 Current Ratio2.67 Quick Ratio2.38 Sales & Book Value Annual Sales$376.57 million Price / Sales24.04 Cash FlowN/A Price / Cash FlowN/A Book Value$7.84 per share Price / Book18.42Miscellaneous Outstanding Shares62,710,000Free Float60,776,000Market Cap$9.05 billion OptionableOptionable Beta2.22 Social Links 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NASDAQ:TWST) was last updated on 9/16/2026 by MarketBeat.com Staff. From Our PartnersWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredGold just passed our debt as the world's #1 assetChina's US Treasury holdings have fallen from a peak of $1.32 trillion to roughly $659 billion, an 18-year low...Behind the Markets | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredNNVC on Alert: FDA Validation and Outperform Rating!NanoViricides (NYSE: NNVC) just landed FDA Rare Pediatric Disease Designation for NV-387 in Measles, adding to...Equiscreen | SponsoredWhat Is A Roth Conversion, And How Do I Set One Up?A Roth conversion moves money from a traditional IRA or employer plan into a Roth IRA, triggering income tax t...SmartAsset | SponsoredMusk says UBI is coming. I say it's already here.Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...Freedom Financial | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Twist Bioscience Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Twist Bioscience With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
